SAR of psilocybin analogs: Discovery of a selective 5-HT2C agonist

SAR of psilocybin analogs: Discovery of a selective 5-HT2C agonist Discovery and Structure–Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT_2A Receptor Agonists Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents Identification of Novel 1-O-Substituted Aporphine Analogues as Potent 5-HT_2C Receptor Agonists Novel Agonists of 5HT_2C Receptors. Synthesis and Biological Evaluation of Substituted 2-(Indol-1-yl)-1-methylethylamines and 2-(Indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved Therapeutics for Obsessive Compulsive Disorder Rational Drug Design Leading to the Identification of a Potent 5-HT_2C Agonist Lacking 5-HT_2B Activity C-(4,5,6-Trimethoxyindan-1-yl)methanamine:  A Mescaline Analogue Designed Using a Homology Model of the 5-HT_2AReceptor Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT_2AReceptor Agonists